Trademark: 90478027
Status Date
Thursday, February 8, 2024
Filing Date
Wednesday, January 20, 2021
Published for Opposition
Tuesday, December 21, 2021
5 Adjuvants for medical purposes; Anti-cancer preparations; Anti-sarcoma preparations; Cellular function activating agents for medical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer and metabolic diseases; Chemotherapeutics; Cytostatics for pharmaceutical purposes; Diagnostic preparations for medical purposes; Medical preparations for the treatment of cancer and metabolic diseases; Medicinal infusions for treating cancer and metabolic diseases; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for cancer and metabolic diseases; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of cancer and metabolic diseases; Pharmaceutical preparations for the treatment and prevention of cancer and metabolic diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer and metabolic diseases; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for cancer and metabolic diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, elixirs for the treatment of cancer and metabolic diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer and metabolic diseases; Tumor suppressing agents
44 Providing a web site featuring medical information; Providing a website featuring information in the field of the diagnosis and treatment of cancer and metabolic diseases
42 Biotechnology research; Development of new technology for others in the field of cancer and metabolic diseases; Development of pharmaceutical preparations and medicines; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and metabolic diseases; Testing of pharmaceuticals
Feb 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 8, 2024
Sou Extension 4 Granted
Feb 8, 2024
Sou Extension 4 Filed
Feb 8, 2024
Sou Teas Extension Received
Aug 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 11, 2023
Sou Extension 3 Granted
Aug 11, 2023
Sou Extension 3 Filed
Aug 11, 2023
Sou Teas Extension Received
Dec 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 16, 2022
Sou Extension 2 Granted
Dec 16, 2022
Sou Extension 2 Filed
Dec 16, 2022
Sou Teas Extension Received
Jun 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 15, 2022
Sou Extension 1 Granted
Jun 15, 2022
Sou Extension 1 Filed
Jun 15, 2022
Sou Teas Extension Received
Jun 10, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 10, 2022
Teas Change Of Correspondence Received
Jun 10, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 10, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 10, 2022
Teas Change Of Owner Address Received
Feb 15, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 21, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 21, 2021
Published For Opposition
Dec 1, 2021
Notification Of Notice Of Publication E-Mailed
Nov 15, 2021
Approved For Pub - Principal Register
Nov 12, 2021
Teas/Email Correspondence Entered
Nov 12, 2021
Correspondence Received In Law Office
Nov 12, 2021
Teas Response To Office Action Received
Jul 15, 2021
Notification Of Non-Final Action E-Mailed
Jul 15, 2021
Non-Final Action E-Mailed
Jul 15, 2021
Non-Final Action Written
Jul 7, 2021
Assigned To Examiner
Jun 11, 2021
Teas Change Of Correspondence Received
Jun 11, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 11, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 21, 2021
New Application Office Supplied Data Entered
Jan 23, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
